Overall, the similarity in the lipid profile of androgen-deprived CRPCs and AA prostate cancer patients indicates that the pY-SREBF1/H2A-K130ac signaling could play a role in race-specific deregulation of lipid pathways in aggressive prostate tumors. Here, SREBF1 is linked to prostate cancer.